RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-4853
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_0826700; Gene model (P.falciparum): PF3D7_0925900; Gene product: lipocalin (LCN, parasitophorous vacuole protein 5, PV5)
Details mutation: 'promoter-swap' mutant; the PbPV5 promoter replaced by the promoter of PBANKA_0931200 (PbHSP101)
Transgene
Transgene not Plasmodium: GFP
Promoter: Gene model: PBANKA_0711900; Gene model (P.falciparum): PF3D7_0818900; Gene product: heat shock protein 70 (HSP70)
3'UTR: Gene model: PBANKA_1340000; Gene product: dihydrofolate synthase/folylpolyglutamate synthase, putative (PbDHFS-FPGS)
Replacement locus: Gene model: Not available; Gene product: Not available
Phenotype Asexual bloodstage;
Last modified: 22 August 2020, 21:30
  *RMgm-4853
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 32601225
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone RMgm-947
Other information parent lineThe mutant (strongly) expresses GFP in all life cycle stages (under the control of the constitutive and strong hsp70 promoter). The Bergreen mutant does not contain a drug-selectable marker. The gfp-gene has been integrated by double cross-over integration into a silent intergenic region on chromosome 6.
The mutant parasite was generated by
Name PI/ResearcherMatz JM, Blackman MJ
Name Group/DepartmentMalaria Biochemistry Laboratory
Name InstituteThe Francis Crick Institute
CityLondon
CountryUK
Name of the mutant parasite
RMgm numberRMgm-4853
Principal namepv5::5′ hsp101
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageGrowth of the promoter swap mutants was significantly impaired, with the pv5::5′hsp101 parasites growing at 54%
Gametocyte/GameteNot tested
Fertilization and ookineteNot tested
OocystNot tested
SporozoiteNot tested
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
In the 'promoter-swap' mutant the PbPV5 promoter replaced by the promoter of PBANKA_0931200 (PbHSP101)

Protein (function)
The protein shows similarity to members of the functionally diverse lipocalin family, barrelshaped proteins capable of binding various hydrophobic ligands and protein interaction partners. The signature lipocalin fold comprises a short amino-terminal 310 helix followed by eight consecutive barrel-forming β-strands, an α-helix, and one more β-strand. In addition, PV5 harbors two predicted preceding amino-terminal β-strands specific to Plasmodium, as well as a signal peptide. Multiple sequence alignments with lipocalins from phylogenetically distant organisms showed the presence of a highly conserved glycine and two aromatic residues within the structurally conserved region 1 (SCR1) of PV5

Phenotype
From the paper: 'Our previous attempts to disrupt the genomic PbPV5 locus resulted only in atypical integration of the targeting construct without perturbing the endogenous gene, which is indicative of essential functions during the asexual blood-stage cycle in vivo. As an alternative genetic strategy to analyze PbPV5 function, we sought to deregulate PbPV5 expression by employing a promoter swap approach. Toward this aim, we generated parasites expressing the endogenous PbPV5 gene from the promoters of Plasmodium translocon of exported proteins 88 (PTEX88) or heat shock protein 101 (HSP101), respectively. Quantitative real-time PCR analysis of the mutants indicated that the knockdown efficiency was ∼60% in asynchronous blood stages. Impaired growth prevented quantification of knockdown levels in synchronized ex vivo early blood stages. Strikingly, in the schizont stage, the mutants exhibited significantly elevated PbPV5 transcript levels, corresponding to ∼3.4 (pv5::5′ ptex88) and ∼5.6-fold (pv5::5′hsp101) more than in WT schizonts, showing that the promoter swap strategy was successful in deregulating the physiological expression of PbPV5 throughout the asexual replication cycle. To investigate whether altered PbPV5 transcription results in reduced parasite fitness, we examined asexual propagation of the mutants in vivo. Growth of the promoter swap mutants was significantly impaired, with the pv5::5′ptex88 parasites growing at 80% and pv5::5′hsp101 parasites at only 54% of the WT growth rate . These results underscore the importance of correct PbPV5 expression during asexual replication of the parasite in vivo'.

Additional information
PbPV5 transcript abundance in the WT and the promoter swap mutants was measured by quantitative real-time PCR (qPCR) and normalized to Pb18S rRNA.

Evidence is presented that:
- PV5 Is Trafficked to the Parasite Digestive Compartments
- PbPV5 'promoter swap' mutants Form Less Hz

Other mutants


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0826700
Gene Model P. falciparum ortholog PF3D7_0925900
Gene productlipocalin
Gene product: Alternative nameLCN, parasitophorous vacuole protein 5, PV5
Details of the genetic modification
Short description of the mutation'promoter-swap' mutant; the PbPV5 promoter replaced by the promoter of PBANKA_0931200 (PbHSP101)
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationTo generate the PbPV5 promoter swap mutants, the 5′ portion of the PbPV5 gene (PBANKA_0826700) was PCR-amplified and cloned into the B3D+ vector using BamHI and SacII. The promoters of PbPTEX88 (PBANKA_0941300) or PbHSP101 (PBANKA_0931200) were then amplified and cloned in front of the start codon using BamHI. Vectors were linearized
with BstBI and transfected into GFP-fluorescent P. berghei Bergreen WT parasites, using standard protocols.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitegfp (FACS)
Promoter of the selectable markerhsp70
Selection (positive) procedureFACS (flowsorting)
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_0711900
Gene Model P. falciparum ortholog PF3D7_0818900
Gene productheat shock protein 70
Gene product: Alternative nameHSP70
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_1340000
Gene productdihydrofolate synthase/folylpolyglutamate synthase, putative
Gene product: Alternative namePbDHFS-FPGS
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite Not available
Gene productNot available
Gene product: Alternative name
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4